1. Share Prices

  2. Proteome Sciences PLC (PRM)

3.30p+0.16 (+5.10%)18 Apr 2024, 16:12
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Proteome Sciences PLC Fundamentals

Company NameProteome Sciences PLCLast Updated2024-04-18
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue295.182 mMarket Cap£9.74 m
PE Ratio17.43Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£0.00EPS Growth (%)21.50
PEG0DPS Growth (%)0
Debt Ratio1.0174Debt Equity Ratio0
Asset Equity Ratio-8.0348Cash Equity Ratio-2.7422
Quick Ratio0.4146Current Ratio0.49
Price To Book Value0ROCE0

Proteome Sciences PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Proteome Sciences PLC Company Financials

Assets20222021
Tangible Assets£1.32 m£1.27 m
Intangible Assets£4.22 m£4.22 m
Investments00
Total Fixed Assets£5.54 m£5.49 m
Stocks£901,000.00£1.09 m
Debtors£1.74 m£980,000.00
Cash & Equivalents£3.99 m£2.39 m
Other Assets00
Total Assets£12.43 m£10.04 m
Liabilities20222021
Creditors within 1 year£12.49 m£11.72 m
Creditors after 1 year£787,000.00£1.10 m
Other Liabilities00
Total Liabilities£13.28 m£12.82 m
Net assets-£843,000.00-£2.77 m
Equity20222021
Called up share capital£2.95 m£2.95 m
Share Premium£51.47 m£51.47 m
Profit / Loss£1.25 m£118,000.00
Other Equity-£843,000.00-£2.77 m
Preference & Minorities00
Total Capital Employed-£843,000.00-£2.77 m
Ratios20222021
Debt Ratio00
Debt-to-Equity00
Assets / Equity-8.0348-8.0348
Cash / Equity-2.7422-2.7422
EPS£0.00£0.00
Cash Flow20222021
Cash from operating activities£2.14 m£793,000.00
Cashflow before financing£1.93 m£393,000.00
Increase in Cash£1.61 m£189,000.00
Income20222021
Turnover£7.78 m£5.13 m
Cost of sales£3.01 m£2.17 m
Gross Profit£4.77 m£2.96 m
Operating Profit£1.73 m£412,000.00
Pre-Tax profit£1.25 m£118,000.00

Proteome Sciences PLC Company Background

SectorHealthcare
ActivitiesProteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.
Latest Interim Date25 Aug 2023
Latest Fiscal Year End Date10 Apr 2024

Proteome Sciences PLC Directors

AppointedNamePosition
2023-04-17Mr. Christopher Donovan James PearceNon-Executive Director,Chairman
2023-04-17Mr. Roger Steven McDowellNon-Executive Director
2014-11-28Mr. James L MalthouseExecutive Director,Company Secretary
2017-08-01Professor William DawsonNon-Executive Director
2014-07-01Mr. Ralph Stephen HarrisNon-Executive Director,Chairman
2023-04-17Dr. Ian PikeExecutive Director,Chief Scientific Officer
2001-06-22Dr. Anthony Ian WalkerNon-Executive Director
2011-08-09Mr. Alfred James Green BScExecutive Director,Commercial Director
2011-08-09Mr. Peter Schulz-knappeExecutive Director,Research and Development Director
2023-04-17Dr. Mariola Gabriela Sohngen Executive Director,Chief Executive Officer
2023-04-14Mr. Martin Henry Diggle Non-Executive Director
2018-05-15Mr. Geoffrey John EllisExecutive Director,Finance Director and Company Secretary
2021-04-07Mr. Jeremy Rupert Michael HaighExecutive Director,Chief Executive Officer
2023-04-17Mr. Richard Paul DennisExecutive Director,Chief Commercial Officer
2023-04-17Mr. Abdelghani OmariExecutive Director,Chief Financial Officer

Proteome Sciences PLC Contact Details

Company NameProteome Sciences PLC
AddressHamilton House, Mabledon Place, London, WC1H 9BB
Telephone+44 193 286-5065
Websitehttps://www.proteomics.com

Proteome Sciences PLC Advisors

Financial PR AdviserIFC Advisory Ltd
Phone+44 2039346630
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2072200597
SolicitorFreeths LLP
Phone+44 8450503200
Fax+44 8450503250
AuditorBDO LLP
Phone+44 2074865888
Fax+44 2074873686
StockbrokerFinnCap
Phone+44 2072200500
Fax+44 2072200597
RegistrarLink Asset Services
Phone+44 8716640300
Fax+44 2086392342
Remuneration ConsultantHalliwell Consulting
Phone+44 2076263301
Fax+44 2076233303
BankBarclays Bank PLC

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
18 Apr 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Mondi PLC1,504.509.30
Darktrace PLC476.203.88
Energean PLC1,019.003.87
Close Brothers Group PLC453.203.09
Ashmore Group PLC184.802.44
Hochschild Mining PLC154.602.38

Fallers

CompanyPrice% Chg
Smith (Ds) PLC358.60-10.26
Man Group PLC251.00-6.55
Marshalls PLC257.50-4.10
Foresight Group Holdings Limited440.00-3.93
Dr. Martens PLC67.30-3.65
Allianz Technology Trust PLC328.50-3.10